BOSTON – In a shocking revelation, Tactile Systems Technology (Tactile) has agreed to pay $550,959 to resolve allegations that it submitted false claims to Medicare seeking reimbursement for medically unnecessary pneumatic compression devices in violation of the federal False Claims Act.
The company, which markets pneumatic compression devices for patients suffering from chronic swelling due to lymphedema and chronic venous insufficiency, was accused of submitting false claims between Jan. 1, 2019 and Dec. 31, 2024. The allegations stated that certain Tactile sales personnel fabricated or amended health care professionals’ medical records and other clinical documentation to secure payment for the devices.
According to the government, Tactile required sales personnel to collect and retain patient medical records, which were then used to submit claims to Medicare for payment. However, it is alleged that the sales personnel inserted false statements into the medical records about patients’ failures to experience relief through basic compression therapy or forged health care professionals’ signatures on doctored medical records.
The claims against Tactile were brought under the whistleblower or qui tam provision of the False Claims Act, which allows private parties to sue on behalf of the government for false claims and receive a share of any recovery. The relators will receive $129,475 from the proceeds of the settlement.
United States Attorney Leah B. Foley and Roberto Coviello, Special Agent in Charge, Health and Human Services-Office of Inspector General made the announcement today. Valuable assistance was provided by the Department of Veterans Affairs and the Defense Criminal Investigative Service.
This matter is being handled by Assistant U.S. Attorney Steven Sharobem of the Office’s Affirmative Civil Enforcement Unit and Civil Chief Abraham R. George.
Tactile Systems Technology, a medical device company, has been ordered to pay $550,959 to resolve allegations of false claims to Medicare. The company markets pneumatic compression devices for patients suffering from chronic swelling due to lymphedema and chronic venous insufficiency.
The allegations state that Tactile sales personnel fabricated or amended health care professionals’ medical records and other clinical documentation to secure payment for the devices. The company required sales personnel to collect and retain patient medical records, which were then used to submit claims to Medicare for payment.
Tactile Systems Technology has agreed to pay $550,959 to resolve allegations of false claims to Medicare. The company markets pneumatic compression devices for patients suffering from chronic swelling due to lymphedema and chronic venous insufficiency.
Tactile required sales personnel to collect and retain patient medical records, which were then used to submit claims to Medicare for payment. The company has agreed to pay $550,959 to resolve allegations of false claims to Medicare.
Tactile Systems Technology, a medical device company, has been ordered to pay $550,959 to resolve allegations of false claims to Medicare. The company markets pneumatic compression devices for patients suffering from chronic swelling due to lymphedema and chronic venous insufficiency.
Tactile Systems Technology, a medical device company, has agreed to pay $550,959 to resolve allegations of false claims to Medicare. The company markets pneumatic compression devices for patients suffering from chronic swelling due to lymphedema and chronic venous insufficiency.
Key Facts
- State: Massachusetts
- Category: Fraud & Financial Crimes
- Source: DOJ Press Release â†â€â€
ðŸâ€Â’ Get the grimiest stories delivered weekly. Subscribe free →